MedicX Fund - Quality portfolio, performing well
MedicX will report its results for the year ended 30 September 2018 in December. H218 included a significant portfolio acquisition and an important...
MedicX Fund - Income and capital growth continuing
MedicX Fund produced a 3.9% EPRA NAV total return in the three months ended 31 December 2017, with EPRA NAV per share increasing to 78.0p from...
MedicX Fund - Strong investment pipeline to continue progress
FY17 saw steady underlying growth in the investment portfolio and recurring earnings. Overall returns were further enhanced by positive revaluation...
Attractive income
MedicX Fund Limited’s portfolio of primary healthcare assets is effectively fully let with 89% of rents paid directly or indirectly by the UK and...
Signs of rental growth
MedicX Fund’s (MXF, MedicX) H117 results show a higher level of investment than we had assumed, with Irish acquisitions funded from equity issuance...
No more insights